Actively Recruiting
A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)
Led by Bristol-Myers Squibb · Updated on 2026-05-14
129
Participants Needed
50
Research Sites
291 weeks
Total Duration
On this page
Sponsors
B
Bristol-Myers Squibb
Lead Sponsor
B
BioNTech SE
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to evaluate the safety and tolerability of Pumitamig alone or in combination with Ipilimumab in participants with first-line advanced or unresectable Hepatocellular Carcinoma (HCC)
CONDITIONS
Official Title
A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Have a confirmed diagnosis of locally advanced or unresectable Hepatocellular Carcinoma (HCC)
- Have an ECOG performance status of 0 or 1
- Have not received prior systemic therapy for advanced or unresectable HCC
- Have measurable disease based on RECIST v1.1 criteria
You will not qualify if you...
- Have significant bleeding or clotting disorders or clear risk of bleeding
- Have had an organ transplant
- Have an autoimmune disease
- Other protocol-defined exclusion criteria apply
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 50 locations
1
Local Institution - 0070
Los Angeles, California, United States, 90064
Not Yet Recruiting
2
Local Institution - 0107
Chicago, Illinois, United States, 60611
Not Yet Recruiting
3
John Theurer Cancer Center at Hackensack University Medical Center
Hackensack, New Jersey, United States, 07601-2191
Actively Recruiting
4
Local Institution - 0100
Mineola, New York, United States, 11501
Not Yet Recruiting
5
Providence Portland Medical Center
Portland, Oregon, United States, 97213
Actively Recruiting
6
Providence St. Vincent Medical Center
Portland, Oregon, United States, 97225
Actively Recruiting
7
Tennessee Oncology
Nashville, Tennessee, United States, 37203
Actively Recruiting
8
Vanderbilt University Medical Center
Nashville, Tennessee, United States, 37232
Actively Recruiting
9
Local Institution - 0083
Seattle, Washington, United States, 98109-1024
Not Yet Recruiting
10
Royal Prince Alfred Hospital
Camperdown, New South Wales, Australia, 2050
Actively Recruiting
11
Local Institution - 0033
Westmead, New South Wales, Australia, 2145
Not Yet Recruiting
12
Sunshine Coast University Hospital
Birtinya, Queensland, Australia, 4575
Actively Recruiting
13
The Royal Melbourne Hospital
Parkville, Victoria, Australia, 3052
Actively Recruiting
14
Bradfordhill
Santiago, Santiago Metropolitan, Chile, 8420383
Actively Recruiting
15
Local Institution - 0106
Santiago Region Metropolitana, Santiago Metropolitan, Chile, 8330034
Not Yet Recruiting
16
Local Institution - 0075
Guangzhou, Guangdong, China, 510515
Not Yet Recruiting
17
Local Institution - 0086
Xi'an, Shaanxi, China, 710126
Not Yet Recruiting
18
Local Institution - 0078
Shanghai, Shanghai Municipality, China, 200032
Not Yet Recruiting
19
Local Institution - 0056
Pessac, Aquitaine, France, 33600
Not Yet Recruiting
20
Local Institution - 0004
Grenoble, Isère, France, 38043
Not Yet Recruiting
21
Local Institution - 0001
Montpellier, Languedoc-Roussillon, France, 34295
Not Yet Recruiting
22
Local Institution - 0018
Saint Priest En Jarez, Pays de la Loire Region, France, 42270
Not Yet Recruiting
23
Local Institution - 0003
Bobigny, France, 93000
Not Yet Recruiting
24
Local Institution - 0031
Cologne, North Rhine-Westphalia, Germany, 50937
Not Yet Recruiting
25
Local Institution - 0028
Kiel, Schleswig-Holstein, Germany, 24105
Not Yet Recruiting
26
Local Institution - 0030
Frankfurt, Germany, D-60590
Not Yet Recruiting
27
Local Institution - 0109
Pisa, Tuscany, Italy, 56126
Not Yet Recruiting
28
Local Institution - 0088
Milan, Italy, 20
Not Yet Recruiting
29
Local Institution - 0089
Milan, Italy, 20132
Not Yet Recruiting
30
Local Institution - 0016
Pisa, Italy, 56126
Not Yet Recruiting
31
Local Institution - 0046
Rozzano (MI), Italy, 20089
Not Yet Recruiting
32
Local Institution - 0021
Wroclaw, Lower Silesian Voivodeship, Poland, 53-439
Not Yet Recruiting
33
Local Institution - 0105
Warsaw, Masovian Voivodeship, Poland, 02-106
Not Yet Recruiting
34
Local Institution - 0020
Gdansk, Poland, 80-952
Not Yet Recruiting
35
Local Institution - 0009
Singapore, Singapore, 119074
Not Yet Recruiting
36
Local Institution - 0012
Singapore, Singapore, 169610
Not Yet Recruiting
37
Local Institution - 0027
Seongnam-si, Gyeonggi-do, South Korea, 13496
Not Yet Recruiting
38
Local Institution - 0013
Seoul, Seoul Teugbyeolsi, South Korea, 06351
Not Yet Recruiting
39
Local Institution - 0011
Seoul, Seoul-teukbyeolsi, South Korea, 05505
Not Yet Recruiting
40
Local Institution - 0014
Pamplona, Navarre, Spain, 31008
Not Yet Recruiting
41
Local Institution - 0015
Barcelona, Spain, 8036
Not Yet Recruiting
42
Local Institution - 0060
Madrid, Spain, 28028
Not Yet Recruiting
43
Local Institution - 0095
Madrid, Spain, 28050
Not Yet Recruiting
44
Local Institution - 0032
Taichung, Taiwan, 404332
Not Yet Recruiting
45
National Cheng Kung University Hospital
Tainan, Taiwan, 704
Actively Recruiting
46
National Taiwan University Hospital
Taipei, Taiwan, 10002
Actively Recruiting
47
Taipei Veterans General Hospital
Taipei, Taiwan, 11217
Actively Recruiting
48
Hammersmith Hospital
London, London, City of, United Kingdom, W12 0HS
Actively Recruiting
49
Cancer Research UK - The Beatson Institute for Cancer Research (Cancer Research UK Beatson Laboratories)
Glasgow, South Western Scotland, United Kingdom, G611BD
Actively Recruiting
50
Local Institution - 0053
Metropolitan Borough of Wirral, United Kingdom, CH63 4JY
Not Yet Recruiting
Research Team
B
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com
CONTACT
F
First line of the email MUST contain NCT # and Site #.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
6
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here